Skyepharma PLC: Skyepharma PLC announces Research Update

marketwire.com     20-May-2008            

LONDON--(Marketwire - The author of the poster, Dr. Ekkehard Beck, stated "Study results suggest that long term treatment with FlutiformTM 100/10?g and FlutiformTM 250/10?g will be a safe therapy for patients with persistent asthma." The results of this trial will form part of the US New Drug... [read full story]                    


*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies